Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Major Depressive Disorder and Kappa Opioid Receptor
Development of κ opioid receptor antagonists. | Semantic Scholar
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
μπανάνα επαναλαμβάνω Τα παραπάνω kappa opioid receptor anxiety depression κλινοσκεπάσματα Επικόλληση Μνημειώδης
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
Opioid Agonists and Antagonists | Anesthesia Key
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach | SpringerLink
Dynorphin, stress, and depression | Semantic Scholar
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
PDF) Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
κ-opioid receptor - Wikipedia
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Major Depressive Disorder and Kappa Opioid Receptor
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Opioid Receptors - Pharmacology
Kappa Opioids, Salvinorin A and Major Depressive Disorder
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
